Women's Cancer Center of Seattle — Seattle, Washington

Women's Cancer Center of Seattle is a clinical research site located in Seattle, Washington, United States 98133.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Women's Cancer Center of Seattle has participated in 9 clinical trials with 5 currently active.

Therapeutic areas: Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), GOG Foundation, NRG Oncology.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Women's Cancer Center of Seattle?

Women's Cancer Center of Seattle has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Women's Cancer Center of Seattle conducted?

Women's Cancer Center of Seattle has 9 clinical trials on record, with 5 currently active. Their work covers Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma.

Is Women's Cancer Center of Seattle accredited by Crixeo Health?

Yes — Women's Cancer Center of Seattle holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Women's Cancer Center of Seattle?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.